GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Debt-to-Asset

MeCure Industries (NSA:MECURE) Debt-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries Debt-to-Asset?

MeCure Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₦0.00 Mil. MeCure Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₦0.00 Mil. MeCure Industries's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₦0.00 Mil.

MeCure Industries Debt-to-Asset Historical Data

The historical data trend for MeCure Industries's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeCure Industries Debt-to-Asset Chart

MeCure Industries Annual Data
Trend
Debt-to-Asset

MeCure Industries Semi-Annual Data
Debt-to-Asset

Competitive Comparison of MeCure Industries's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, MeCure Industries's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeCure Industries's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MeCure Industries's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where MeCure Industries's Debt-to-Asset falls into.


;
;

MeCure Industries Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

MeCure Industries's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

MeCure Industries's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeCure Industries  (NSA:MECURE) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

MeCure Industries Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of MeCure Industries's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

MeCure Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Debt-to-Asset
Comparable Companies
Traded in Other Exchanges
N/A
Address
Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA
Website
https://www.mecure.com
MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines